Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies

Bioorganic & Medicinal Chemistry Letters
2010.0

Abstract

Ten novel 3,5-diaryl pyrazolines were synthesized and investigated for their monoamine oxidase (MAO) inhibitory property. All the molecules were found to be reversible and selective inhibitor for either one of the isoform (MAO-A or MAO-B). Further insights in the theoretical evaluation of the possible interactions between the compounds and monoamine oxidases (MAO-A or MAO-B) have been developed through docking studies. The theoretical values are in congruence with their experimental values.

Knowledge Graph

Similar Paper

Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies
Bioorganic & Medicinal Chemistry Letters 2010.0
Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies
Bioorganic & Medicinal Chemistry 2010.0
New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity
Bioorganic & Medicinal Chemistry 2009.0
Pyrazoline based MAO inhibitors: Synthesis, biological evaluation and SAR studies
Bioorganic & Medicinal Chemistry Letters 2011.0
Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis
ACS Medicinal Chemistry Letters 2016.0
Monoamine Oxidase Isoform-Dependent Tautomeric Influence in the Recognition of 3,5-Diaryl Pyrazole Inhibitors
Journal of Medicinal Chemistry 2007.0
Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives
European Journal of Medicinal Chemistry 2008.0
Development of selective and reversible pyrazoline based MAO-B inhibitors: Virtual screening, synthesis and biological evaluation
Bioorganic & Medicinal Chemistry Letters 2011.0
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase
European Journal of Medicinal Chemistry 2010.0
Synthesis and molecular modelling studies of prenylated pyrazolines as MAO-B inhibitors
Bioorganic & Medicinal Chemistry Letters 2010.0